Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis

被引:432
作者
Kuo, Phillip H.
Kanal, Emanuel
Abu-Alfa, Ali K.
Cowper, Shawn E.
机构
[1] Yale Univ, Sch Med, Dept Diagnost Radiol, New Haven, CT 06520 USA
[2] Yale Univ, Sch Med, Dept Internal Med, Nephrol Sect, New Haven, CT 06520 USA
[3] Yale Univ, Sch Med, Dept Dermatol & Pathol, New Haven, CT 06520 USA
[4] Univ Pittsburgh, Med Ctr, Dept Radiol, Pittsburgh, PA USA
关键词
D O I
10.1148/radiol.2423061640
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
While at this time there are more questions than answers, the recognition of an epidemiologic association between the administration of gadolinium-based MR contrast agents and the development of nephrogenic systemic fibrosis prompts caution in the use of these agents in the setting of renal disease. © RSNA, 2007.
引用
收藏
页码:647 / 649
页数:3
相关论文
共 12 条